Bolt Biotherapeutics Inc (BOLT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Sales | 1,141 | 1,275 | 5,274 | 2,089 | 2,528 |
| Gross Profit | 1,141 | 1,275 | 5,274 | 2,089 | 2,528 |
| Operating Expenses | 17,584 | 23,872 | 22,366 | 21,855 | 20,711 |
| Operating Income | -16,443 | -22,597 | -17,092 | -19,766 | -18,183 |
| Other Income | 1,267 | 1,402 | 6,281 | 1,863 | 1,926 |
| Pre-tax Income | -15,176 | -21,195 | -10,811 | -17,903 | -16,257 |
| Net Income Continuous | -15,176 | -21,195 | -10,811 | -17,903 | -16,257 |
| Net Income | $-15,176 | $-21,195 | $-10,811 | $-17,903 | $-16,257 |
| EPS Basic Total Ops | -7.93 | -11.12 | -5.60 | -9.40 | -8.60 |
| EPS Basic Continuous Ops | -7.93 | -11.12 | -5.68 | -9.44 | -8.59 |
| EPS Diluted Total Ops | -7.93 | -11.12 | -5.60 | -9.40 | -8.60 |
| EPS Diluted Continuous Ops | -7.93 | -11.12 | -5.68 | -9.44 | -8.59 |
| EPS Diluted Before Non-Recurring Items | -8.00 | -11.20 | -5.60 | N/A | N/A |
| EBITDA(a) | $-16,486 | $-22,931 | $-17,667 | $-20,493 | $-19,056 |